Sven Ante Lundberg's Net Worth

$24.4 Million

Estimate Recalculated Jun 10, 2025 09:31PM EST

Who is Sven Ante Lundberg

Sven Ante Lundberg has an estimated net worth of $24.4 Million. This is based on reported shares across multiple companies, which include Merus N.V., Vor Biopharma Inc., CRISPR Therapeutics AG, and Homology Medicines, Inc..

SEC CIK

Sven Ante Lundberg's CIK is 0001682126

Past Insider Trading and Trends

2021 was Sven Ante Lundberg's most active year for acquiring shares with 6 total transactions. Sven Ante Lundberg's most active month to acquire stocks was the month of July. 2021 was Sven Ante Lundberg's most active year for disposing of shares, totalling 5 transactions. Sven Ante Lundberg's most active month to dispose stocks was the month of February. 2021 saw Sven Ante Lundberg paying a total of $1,190,341.06 for 473,900 shares, this is the most they've acquired in one year. In 2021 Sven Ante Lundberg cashed out on 163,000 shares for a total of $200,474.46, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merus N.V.

President, CEO & PEO
Updated May 09, 2024
Form 4
360.00K
May 09, 2024
360.00K
Grant
May 07
Form 4
380.00K
Feb 03, 2023
380.00K
Grant
Feb 02
Form 4
56.85%
14.71K
$14.38
$211.43K
Nov 03, 2022
78.07K
Purchase
Nov 03
Form 4/A
Oct 24, 2022
37.50K
Form 4
29.07%
5.83K
$22.92
$133.56K
Aug 23, 2022
25.87K
Purchase
Aug 22
Form 4
3.64%
704.00
$22.99
$16.19K
Aug 22, 2022
20.04K
Purchase
Aug 19
Form 4
28.93%
4.34K
$22.97
$99.68K
Jul 13, 2022
19.34K
Purchase
Jul 12
Form 4
295.00K
Feb 02, 2022
295.00K
Grant
Jan 31
Form 4
$13.20
Aug 04, 2021
357.92K
Options
Aug 02
Form 4/A
Apr 12, 2021
37.50K
Form 4
-100.00%
-74.00K
Mar 29, 2021
111.50K
Grant
Mar 25
Form 4
$13.38
$989.87K
Mar 03, 2021
431.92K
Options
Mar 01
Form 4
368.00K
Feb 18, 2021
368.00K
Grant
Feb 16
Form 4
414.92K
Jan 06, 2020
414.92K
Grant
Jan 03
Form 3
Jan 02, 2020
37.50K
Showing 15 results

Vor Biopharma Inc.

Investor
Updated May 28, 2024
Form 4
30.00K
May 28, 2024
30.00K
Grant
May 23
Form 4
30.00K
Jun 02, 2023
30.00K
Grant
May 26
Form 4
16.91K
Jun 16, 2022
16.91K
Grant
Jun 14
Form 4
16.90K
Feb 09, 2021
16.90K
Grant
Feb 05
Form 3
Feb 04, 2021
29.43K
Showing 5 results

CRISPR Therapeutics AG

Chief Scientific Officer
Updated Feb 10, 2017
Form 4
0.04%
400.00
$14.00
$5.60K
Feb 10, 2017
1.01M
Purchase
Oct 24
Form 3
Oct 18, 2016
505.22K
Showing 2 results

Homology Medicines, Inc.

Investor
Updated Mar 27, 2024
Form 4
12.77K
Mar 27, 2024
12.77K
Grant
Mar 25
Form 3
Mar 27, 2024
1.20K
Showing 2 results